Upstream Bio, Inc. (UPB) - Latest Market Data

Price & Market Data

Price: $8.95

Daily Change: -$0.16 / 1.79%

Daily Range: $8.83 - $9.14

Market Cap: $487,058,880

Daily Volume: 467,443

Performance Metrics

1 Week: -1.86%

1 Month: -12.51%

3 Months: -67.82%

6 Months: -61.02%

1 Year: -5.79%

YTD: -67.03%

About Upstream Bio, Inc. (UPB)

A detailed overview of Upstream Bio, Inc. (UPB) reveals a price of 8.95 and a daily shift of -$0.16 / 1.79%. The market cap is currently 487,058,880. Comprehensive performance figures for 1-week (-1.86%) and 3-month (-67.82%) periods are available.

Company Details

Employees: 75

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.

Selected stocks

Dianthus Therapeutics, Inc. (DNTH)

Bgin Blockchain Limited (BGIN)

FS Bancorp, Inc. (FSBW)

Nebius Group N.V. (NBIS)